33W-17332-34529
1 vaccination
3 coded responses
8 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 300 / GA
- Registered
- 2021-01-04
- Relationship
- Self
Timeline
-
2021-01-04
Registered in v-safe
-
2021-01-04
Dose 1 — Moderna
-
2021-01-04
Survey response — day 0, dose 1MedDRA: Rhinorrhoea — Feeling: Good · Site: PainFree text: Runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-05
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
-
2021-01-06
Survey response — days 1–6 daily, dose 1MedDRA: Diplopia — Feeling: GoodFree text: Double vision for 5 minutes- scaryMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-08
Survey response — days 1–6 daily, dose 1MedDRA: Asthenopia — Feeling: GoodFree text: Eyes feel strainedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-10
- 2021-01-11
- 2021-01-18
- 2021-01-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-04 | Moderna |
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): Runny nose
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Double vision for 5 minutes- scary
Systemic reaction (other): Eyes feel strained
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Asthenopia | ✓ | ✓ | ✓ |
| SRO | Diplopia | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release